1694.4000 15.20 (0.91%)
NSE Jun 09, 2025 15:31 PM
Volume: 2.6M
 

1694.40
0.91%
KRChoksey
Global specialty grew at 11.1% Y-o-Y (-8.7% Q-o-Q) to USD 271 Mn (19.1% of revenue) driven by ILLUMYA, Cequa, WINLEVI, and Odomzo in Q4FY24. It can be noted that large part of the global specialty sales accrue in the US.
Sun Pharmaceutical I.. has an average target of 2039.89 from 9 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended